Dementia as a Contemporary Challenge for Providing Care for the Aging Populations

• Autorzy: Alicja Klich-Rączka
• Języki publikacji: EN

Abstrakty

EN

Dementia occurs with a frequency of 10-12% in the entire geriatric population and 33-50% in people over 90 years of age. The most common cause of dementia are: Alzheimer's disease, rarely vascular dementia, dementia with Lewy bodies, frontotemporal dementia and Parkinson's disease with dementia. There are no medicaments to prevent dementia and effectively treat it. The treatment only slows the progression and improves the quality of life of the patient and caregiver. Taking care of a patient with dementia burdens the caregiver. As the disease progresses, care time extends even to the entire day. Over 90% of caregivers in Poland are family carers. Over 90% of patients stay in their own home until death. The cost of care is high and increases with the duration of the disease. In the case of agitated patients, the cost is higher. Institutional care is more expensive than home care. In Poland, there are no good system solutions in care for a dementia patient. Caregivers do not receive proper support from the government and subordinate units. (original abstract)

Słowa kluczowe

EN

Elderly people; Care for the elderly; Chronic diseases; Health costs; Ageing of the population; Health care

PL

Ludzie starsi; Opieka nad osobami starszymi; Choroby przewlekłe; Koszty ochrony zdrowia; Starzenie się społeczeństw; Opieka zdrowotna

• Czasopismo: Zdrowie Publiczne i Zarządzanie
• Rocznik: 2019
• Tom: 17
• Numer: nr 1
• Strony: 16--25

Twórcy

autor

Alicja Klich-Rączka

• Jagiellonian University

Bibliografia

• https://stat.gov.pl/obszary-tematyczne/roczniki-statystyczne/roczniki-statystyczne/rocznik-demograficzny-2018,3,12.html (accessed: 10.04.2019).
• Szukalski P., Decomposition of changes in life expectancy by age groups, Poland, 1950-2008, "Przegl. Epidemiol." 2010; 64 (3): 425-430.
• Piotrowicz K., Pac A., Skalska A.B., Chudek J., Klich-Rączka A., Szybalska A., Michel J.P., Grodzicki T., Clustering of geriatric deficits emerges to be an essential feature of ageing - results of a cross-sectional study in Poland, "Aging (Albany NY)" 2016; 8 (10): 27.
• Klich-Rączka A., Siuda J., Piotrowicz K., Boczarska-Jedynak M., Skalska A., Krzystanek E., Wizner B., Świat M., Skrzypek M., Opala G., Grodzicki T., Zaburzenia funkcji poznawczych u osób w starszym wieku, in: Mossakowska M., Więcek A., Błędowski P. (eds.), Aspekty medyczne, psychologiczne, socjologiczne i ekonomiczne starzenia się ludzi w Polsce, Termedia Wydawnictwa Medyczne, Poznań 2012.
• Skalska A., Wizner B., Piotrowicz K., Klich-Rączka A., Klimek E., Mossakowska M., Rowiński R., Kozak-Szkopek E., Jóźwiak A., Gąsowski J., Grodzicki T., The prevalence of falls and their relation to visual and hearing impairments among a nationwide cohort of older Poles, "Exp. Gerontol." 2013; 48 (2): 140-146.
• Diagnostyka i leczenie otępień. Rekomendacje zespołu ekspertów Polskiego Towarzystwa Alzheimerowskiego, Wydawnictwo Medisfera, Otwock 2012.
• Garre-Olmo J., Garcia-Ptacek S., Calvó-Perxas L., Turró-Garriga O., López-Pousa S., Eriksdotter M., Diagnosis of dementia in the specialist setting: A comparison between the Swedish Dementia Registry (SveDem) and the Registry of Dementias of Girona (ReDeGi), "J. Alzheimers Dis." 2016; 53 (4): 1341-1345.
• Mayeux R., Stern Y., Epidemiology of Alzheimer Disease, "Cold Spring Harb. Perspect. Med." 2012; 2 (8): a006239.
• Ferri C.P., Prince M., Brayne C., Brodaty H., Fratiglioni L., Ganguli M., Hall K., Hasegawa K., Hendrie H., Huang Y., Jorm A., Mathers C., Menezes P.R., Rimmer E., Scazufca M., Alzheimer's Disease International: Global prevalence of dementia: A Delphi consensus study, "Lancet" 2005; 366 (9503): 2112-2117.
• Klich-Rączka A., Piotrowicz K., Mossakowska M., Skalska A., Wizner B., Broczek K., Wieczorowska-Tobis K., Grodzicki T., The assessment of cognitive impairment suspected of dementia in Polish elderly people: Results of the population-based PolSenior Study, "Exp. Gerontol." 2014; 57: 233-242.
• Langa K.M., Levine D.A., The diagnosis and management of mild cognitive impairment: a clinical review, "JAMA" 2014; 312 (23): 2551-2561.
• Petersen R.C., Lopez O., Armstrong M.J., Getchius T.S.D., Ganguli M., Gloss D., Gronseth G.S., Marson D., Pringsheim T., Day G.S., Sager M., Stevens J., Rae-Grant A., Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology, "Neurology" 2018, 16; 90 (3): 126-135.
• Parnowski T., Szczudlik A., Sobów T., Gabryelewicz T., Zaburzenia neuropsychiatryczne w otępieniach. Uaktualnione zasady terapii, Mediadore, Warszawa 2018.
• Norton S., Matthews F.E., Barnes D.E., Yaffe K., Brayne C., Potential for primary prevention of Alzheimer's disease: An analysis of population-based data, "Lancet Neurol." 2014; 13 (8): 788-794.
• Volkert D., Chourdakis M., Faxen-Irving G., Frühwald T., Landi F., Suominen M.H., Vandewoude M., Wirth R., Schneider S.M., ESPEN guidelines on nutrition in dementia, "Clin. Nutr." 2015; 34 (6): 1052-1073.
• Park-Wyllie L.Y., Mamdani M.M., Li P., Gill S.S., Laupacis A., Juurlink D.N., Cholinesterase inhibitors and hospitalization for bradycardia: A population-based study, "PLoS Med." 2009; 6 (9).
• Pariente A., Sanctussy D.J., Miremont-Salamé G., Moore N., Haramburu F., Fourrier-Réglat A., L'Association Française des Centres Régionaux de Pharmacovigilance (CRPV): Factors associated with serious adverse reactions to cholinesterase inhibitors: a study of spontaneous reporting, "CNS Drugs" 2010; 24 (1): 55-63.
• Little M.O., Updates in nutrition and polypharmacy, "Curr. Opin. Clin. Nutr. Metab. Care" 2018; 21 (1): 4-9.
• Soler A., Amer G., Leiva A., Ripoll J., Llorente M.A., Leiva A., Taltavull J.M., Molina R., Llobera J., Continuation versus discontinuation of treatment for severe dementia: Randomized, pragmatic, open-label, clinical trial to evaluate the efficacy of continuing drug treatment in patients with severe dementia (STOP-DEM), "BMC Geriatr." 2019; 19 (1): 101.
• Kuo Y.C., Rajesh R., Challenges in the treatment of Alzheimer's disease: Recent progress and treatment strategies of pharmaceuticals targeting notable pathological factors, "Expert Rev. Neurother." 2019 May 20. doi: 10.1080/14737175.2019.1621750. [Epub ahead of print].
• Amjad H., David L., Roth D.L., Samus Q.M., Yasar S., Wolff J.L., Potentially unsafe activities and living conditions in older adults with dementia, "J. Am. Geriatr. Soc." 2016; 64 (6): 1223-1232.
• Sytuacja osób chorych na chorobę Alzheimera w Polsce. Raport RPO, Biuro Rzecznika Praw Obywatelskich, Warszawa 2016; https://www.rpo.gov.pl/sites/default/files/Sytuacja%20os%C3%B3b%20chorych%20na%20chorob%C4%99%20Alzheimera%20wyd.II_.pdf (accessed: 02.04.2019).
• Karczewska B., Bień B., Ołdak E., Jamiołkowski J., Opiekunowie rodzinni osób starszych z otępieniem lub zaburzeniami poznawczymi w Polsce - czynniki ryzyka obciążenia opieką, "Gerontologia Polska" 2012; 20: 2.
• Black C.M., Ritchie C.W., Khandker R.K., Wood R., Jones E., Hu X., Ambegaonkar B.M., Non-professional caregiver burden is associated with the severity of patient' cognitive impairment, "PLoS One" 2018; 13 (12).
• Klich-Rączka A., Głaś M., Grodzicki T., Stan funkcji poznawczych a zaniedbanie i samozaniedbanie, in: TobiaszAdamczyk B., Brzyska M., Grodzicki T. (eds.), Zaniedbanie i samozaniedbanie osób starszych. Medyczne i społeczne uwarunkowania, Ed. I, Wydawnictwo Uniwersytetu Jagiellońskiego, Kraków 2019: 105-119.
• Sutcliffe C., Giebel C., Bleijlevens M., Lethin C., Stolt M., Saks K., Soto M.E., Meyer G., Zabalegui A., Chester H., Challis D., on behalf of the RightTimePlaceCare Consortium, Caring for a person with dementia on the margins of long-term care: A perspective on Burden from 8 European countries, "J. Am. Med. Dir. Assoc." 2017; 18 (11): 967-973.
• Luengo-Fernandez R., Leal J., Gray A.M., UK research expenditure on dementia, heart disease, stroke and cancer: Are levels of spending related to disease burden? "Eur. J. Neurol." 2012; 19 (1): 149-154.
• Cantarero-Prieto D., Leon P.L., Blazquez-Fernandez C., Juan P.S., Cobo C.S., The economic cost of dementia: A systematic review, "Dementia (London)" 2019; Mar 25: 1471301219837776 [Epub ahead of print].
• Deb A., Thornton J.D., Sambamoorthi U., Innes K., Direct and indirect cost of managing alzheimer's disease and related dementias in the United States, "Expert. Rev. Pharmacoecon Outcomes Res." 2017; 17 (2): 189-202.
• Wimo A., Reed C.C., Dodel R., Belger M., Jones R.W., Happich M., Argimon J.M., Bruno G., Novick D., Vellas B., Haro J.M., The GERAS Study: A prospective observational study of costs and resource use in community dwellers with Alzheimer's disease in three European countries - study design and baseline findings, "J. Alzheimers Dis." 2013; 36 (2): 385-399.
• Lenox-Smith A., Reed C., Lebrec J., Belger M.W., Resource utilisation, costs and clinical outcomes in non-institutionalised patients with Alzheimer's disease: 18-month UK results from the GERAS observational study, "BMC Geriatr." 2016; 16 (1): 195.
• Olazarán J., Agüera-Ortiz L., Argimón J.M., Reed C., Ciudad A., Andrade P., Dilla T., Costs and quality of life in community-dwelling patients with Alzheimer's disease in Spain: Results from the GERAS II observational study, "Int. Psychogeriatr." 2017; 29 (12): 2081-2093.
• Bruno G., Mancini M., Bruti G., Dell'Agnello G., Reed C., Costs and resource use associated with Alzheimer's disease in Italy: Results from an observational study, "J. Prev. Alzheimers Dis." 2018; 5 (1): 55-64.
• Belger M., Haro J.M., Reed C., Happich M., Argimon J.M., Bruno G., Dodel R., Jones R.W., Vellas B., Wimo A., Determinants of time to institutionalisation and related healthcare and societal costs in a community-based cohort of patients with Alzheimer's disease dementia, "Eur. J. Health Econ." 2019; 20 (3): 343-355.
• Tucker S., Sutcliffe C., Bowns I., Challis D., Saks K., Verbeek H., Cabrera E., Karlsson S., Leino-Kilpi H., Meyer G., Soto M.E., RightTimePlaceCare Consortium: Improving the mix of institutional and community care for older people with dementia: An application of the balance of care approach in eight European countries, "Aging Ment. Health" 2016; 20 (12): 1327-1338.
• Wübker A., Zwakhalen S.M., Challis D., Suhonen R., Karlsson S., Zabalegui A., Soto M., Saks K., Sauerland D., Costs of care for people with dementia just before and after nursing home placement: primary data from eight European countries, "Eur. J. Health Econ." 2015; 16 (7): 689-707.
• Schaller S., Mauskopf J., Kriza C.., Wahlster P, Kolominsky-Rabas P.L., The main cost drivers in dementia: a systematic review, "Int. J. Geriatr. Psychiatry" 2015; 30 (2): 111-129.
• Livingston G., Barber J., Marston L., Stringer A., Panca M., Hunter R., Cooper C., Laybourne A., La Frenais F., Reeves S., Manela M., Lambe K., Banerjee S., Rapaport P., Clinical and cost-effectiveness of the Managing Agitation and Raising Quality of Life (MARQUE) intervention for agitation in people with dementia in care homes: A single-blind, cluster-randomised controlled trial, "Lancet Psychiatry" 2019; 6 (4): 293-304.
• Panca M., Livingston G., Barber J., Cooper C., La Frenais F., Marston L., Cousins S., Hunter R.M., Healthcare resource utilisation and costs of agitation in people with dementia living in care homes in England - The Managing Agitation and Raising QUality of LifE in Dementia (MARQUE) study, "PLoS One" 2019; 14 (2): e0211953.
• Costa N., Wübker A., De Mauléon A., Zwakhalen S.M.G., Challis D., Leino-Kilpi H., Hallberg I.R., Stephan A., Zabalegui A., Saks K., Molinier L., Wimo A., Vellas B., Sauerland D., Binot I., Soto M.E., RightTimePlaceCare consortium costs of care of agitation associated with dementia in 8 European countries: Results from the RightTimePlaceCare Study, "J. Am. Med. Dir. Assoc." 2018;19 (1): 95.e1-95.e10.
• Durda M., Organizacja opieki nad ludźmi z demencją, "Gerontologia Polska"; 18 (2): 76-85.
• http://www.alzheimer-europe.org/Policy-in-Practice2/National-Dementia-Plans (accessed: 12.04.2019).

Identyfikatory

DOI

10.4467/20842627OZ.19.003.11299